• Tidak ada hasil yang ditemukan

https://links.lww.com/JOT/B822

N/A
N/A
Protected

Academic year: 2024

Membagikan "https://links.lww.com/JOT/B822"

Copied!
4
0
0

Teks penuh

(1)

Tables, Supplemental Digital Content 1.

Adverse Events and Outcomes by Fracture Type (Pelvis and Acetabulum)

Patients (% total) Direct Admission n=1007 (65.3)

Interfacility Transfer n=534 (34.7)

Odds Ratio, Interfacility Transfer (95% CI)

P- Value

Any Adverse Event**

342(34.0) 231 (43.3) 1.48 (1.20-1.84) <0.01

Major Adverse Events**

89 (8.8) 84 (15.7) 1.93 (1.40-2.65) <0.01

Infectious Complications

77 (7.6) 48 (9.0) 1.19 (0.82-1.74) 0.38

Mortality 32 (2.1) 21 (1.4) 1.25 (0.71-2.19) 0.46

Readmission 63 (6.3) 42 (7.9) 1.28 (0.85-1.92) 0.24

Length of Stay* 6.9+/- 7.8 7.7 +/- 7.8 0.04

Operative Time** 117 +/-91minutes 151 +/- 98 minutes <0.001

*p-value<0.05, **=p-value<0.01, statistically significant, CI=Confidence Interval

Adverse Events and Outcomes by Fracture Type (Femur)

Patients (% total) Direct Admission

Interfacility Transfer

Odds Ratio, Interfacility

P-Value

(2)

n=8134 (74.0)

n=2862 (26.0) Transfer (95%

Confidence Interval)

Any Adverse Event 3364 (41.4) 1430 (50.0) 1.42 (1.30-1.54) <0.01 Major Adverse

Events*

862 (10.6) 403 (14.1) 1.38(1.22-1.57) <0.01

Infectious Complications

641 (7.9) 253 (8.8) 113 (0.97-1.32) 0.11

Mortality 32 (2.1) 21 (1.4) 1.25 (0.71-2.19) 0.46

Readmission 550 (6.8) 182 (6.4) 0.94 (0.79-1.11) 0.49

Length of Stay* 5.9 +/- 10.5 6.5 +/- 8.5 <0.01

Operative Time* 105 +/-58 minutes 109 +/- 55 minutes <0.01

*p-value<0.05, **=p-value<0.01, statistically significant, CI=Confidence Interval

(3)

Adverse Events and Outcomes by Fracture Type (Tibia and Patella)

Patients (% total) Direct Admission n=9665 (85.3)

Interfacility Transfer n=1671 (14.7)

Odds Ratio, Interfacility Transfer (95%

CI)

P-Value

Any Adverse Event**

1021 (10.6) 259 (15.5) 1.55 (1.23-1.80) <0.01

Major Adverse Events*

481 (5.0) 106 (6.3) 1.29 (1.04-1.61) 0.02

Infectious Complications**

341 (3.5) 92 (5.5) 1.59 (1.26-2.02) <0.01

Mortality* 60 (0.6) 20 (1.2) 1.94 (1.12-3.23) <0.01 Readmission* 438 (4.5) 95 (5.7) 1.27 (1.01-1.60) 0.04 Length of Stay** 3.9 +/- 5.8 days 5.1 +/- 7.3 days <0.01 Operative Time 105 +/- 58 minutes 108 +/- 60minutes 0.14

*p-value<0.05, **=p-value<0.01, statistically significant, CI=Confidence Interval

(4)

Adverse Events and Outcomes by Fracture Type (Foot and Ankle)

Patients (% total) Direct Admission n=13524 (86.8)

Interfacility Transfer n=1990 (13.2)

Odds Ratio, Interfacility Transfer (95% CI)

P-Value

Any Adverse Event**

996 (7.4) 238 (11.3) 1.61 (1.38-1.87) <0.01

Major Adverse Events**

546 (4.0) 138 (6.6) 1.67 (1.38-2.03) <0.01

Infectious Complications*

455 (3.4) 110 (5.2) 1.59 (1.28-1.97) <0.01

Mortality* 66 (0.5) 27 (1.3) 2.66 (1.69-4.17) <0.01

Readmission 514 (3.8) 99 (16.2) 1.25 (1.01-1.56) 0.05

Discharge Other than Home**

11936 (36.9)

3829 (53.4) OR 1.96 (1.86- 2.06)

<0.001

Length of Stay** 3.5 +/- 7.7 4.1 +/-9.5 <0.01

Operative Time** 91 +/- 57 minutes 87 +/- 56 minutes <0.01

*p-value<0.05, **=p-value<0.01, statistically significant, CI=Confidence Interval

Referensi

Dokumen terkait

Supplemental Digital Content 1,

1 Supplemental Digital Content Table of Contents Supplemental Digital Appendix 1: Variable Direct Costs of Utilization Categories ...2-3 Supplemental Digital Appendix 2: Frequencies

Supplemental Digital Content Table 1, Supplemental Digital Content 1: Differentially expressed micro-RNAs miRNAs in arteriovenous AV loops compared to controls in miRNA microarray

Supplemental Digital Content 5F: Statistical analysis of conclusive results according to histopathological analysis in open

Supplemental Digital Content 1 Table

BMI, body mass index; CNR, contrast-to-noise ratio; HU, Hounsfield unit; SNR, signal-to- noise ratio Supplemental Digital Content

Supplemental Digital Content Supplemental

Supplemental Digital Content Search Strategy PubMed "neurosurg*"[tiab] OR "neurological surgery"[tiab] OR "neurosurgery"[mesh] OR "neurosurgical procedures"[mesh] OR "brain"[mesh]